Key information

🔎 Fund Overview

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. The company operates through Medical Devices and U.S. Medical Supplies segments. It sells advanced surgical solutions comprising stapling, vessel sealing, fixation (hernia mechanical devices), mesh, hardware and ablation products, and interventional lung and gastrointestinal solutions, as well as general surgical solutions, including surgical instruments, sutures, and electrosurgery products; and peripheral vascular therapies, such as compression, dialysis, venous insufficiency, peripheral stents, directional artherectomy, and other products, as well as neurovascular therapies comprising coils, neurovascular stents, flow diversion products, and access and delivery products to support procedures. The company also offers patient monitoring products, such as sensors, monitors, and temperature management products; airway and ventilation products, including airway, ventilator, and inhalation therapy products, as well as breathing systems; and nursing care products comprising incontinence, wound care, enteral feeding, urology, and suction products. In addition, it sells patient care products, such as operating room supply products and electrodes; original equipment manufacturer products; and SharpSafety products comprising needles, syringes, and sharps disposal products. The company’s products are used primarily by hospitals and ambulatory care centers, as well as alternate site healthcare providers, such as physician offices. It markets its products through direct sales force and third-party distributors. Covidien plc is based in Dublin, Ireland.